DelveInsight’s Androgenetic Alopecia Market Insights report provides a thorough understanding of current treatment practices, emerging Androgenetic Alopecia market share of the individual therapies, current and forecasted Androgenetic Alopecia market size from 2018 to 2030 segmented into 7MM (the USA, EU5 (the UK, Italy, Spain, France, and Germany), and Japan).

 

Androgenetic Alopecia Overview

Androgenetic Alopecia (AGA) or hair loss, is often referred to as ‘Male Pattern Baldness’ or ‘Female Pattern Baldness’. Hair loss is a matter of enormous public interest and it significantly impacts the patient’s mental health. In-depth insights of pathophysiology and treatment landscape of various types of alopecia is imperative to exert a positive influence on the quality of life of the patients.

 

Learn more about the report offerings @ https://www.delveinsight.com/sample-request/androgenetic-alopecia-market

 

Some of the key highlights of the Androgenetic Alopecia Market Report

• Varied sources of published literature has suggest higher prevalence of AGA in males as compared to females; however, severity may vary in different age groups and race ethnicities.
• The prevalence of vertex and full AGA increased with age from approximately 30% (age 40–55 years) to 50% (age 65–69 years).
• Rhodes et al. specified that the prevalence of moderate or severe male AGA was approximately 50% in the age group 40–49.
• Androgenetic Alopecia companies are included like Samumed, Follicum AB, Cassiopea and many others.
• Androgenetic Alopecia drugs are included likeClascoterone solution, FOL-005, and many others.

 

Download Sample Report @ https://www.delveinsight.com/sample-request/androgenetic-alopecia-market

 

Androgenetic Alopecia Causes

AGA is caused by a combination of genetic and hormonal factors. Dihydrotestosterone (DHT) is the main hormone responsible for AGA in genetically susceptible individuals. DHT causes scalp hair loss by inducing a change in the hair follicles on the scalp.

 

Androgenetic Alopecia Diagnosis

The diagnosis is based on the evaluation of underlying medical history and is usually done as a three stage physical examination of the scalp, follicular unit and density. ‘Pull technique is also usd to clinically assess AGA.

 

Androgenetic Alopecia Treatment

The current treatment landscape has only minoxidil and finasteride that are FDA approved. There are other off-label therapies such as Ketaconazole and Spironolactone that govern the prescription pattern. This pattern is likely to change post launch of potential pipeline products (Clascoterone, FOL-005) in the next decade.

 

Request Sample Report @ https://www.delveinsight.com/sample-request/androgenetic-alopecia-market

 

Androgenetic Alopecia Emerging Therapy Assessment

The approval of the emerging treatments will be a milestone for patients who have been suffering from Androgenetic Alopecia. The pipeline of Androgenetic Alopecia is not very remarkable. However, there are players including Follicum AB and Cassiopea Inc., with potential product under development. There are many other ongoing studies on combination of patented products such Redensyl and Sepicontrol A5, as an alternative therapy to standard approaches for Androgenetic Alopecia.

 

Androgenetic Alopecia Market Report Scope

• The report covers the descriptive overview of Androgenetic Alopecia, explaining its causes, signs and symptoms, pathophysiology, diagnosis and currently available therapies
• Comprehensive insight has been provided into the Androgenetic Alopecia epidemiology and treatment in the 7MM
• Additionally, an all-inclusive account of both the current and emerging therapies for Androgenetic Alopecia is provided, along with the assessment of new therapies, which will have an impact on the current treatment landscape
• A detailed review of the Androgenetic Alopecia market; historical and forecasted is included in the report, covering drug outreach in the 7MM
• The report provides an edge while developing business strategies, by understanding trends shaping and driving the global Androgenetic Alopecia market

 

Androgenetic Alopecia Companies

• Samumed
• Follicum AB
• Cassiopea
• And many others

 

Androgenetic Alopecia Drugs

• Clascoterone solution
• FOL-005
• And many others

 

Click to get a snapshot of the Androgenetic Alopecia Market Report @ https://www.delveinsight.com/sample-request/androgenetic-alopecia-market

 

Table of Content

1. Key Insights

2. Executive Summary of Androgenetic Alopecia

3. Competitive Intelligence Analysis for Androgenetic Alopecia

4. Androgenetic Alopecia: Market Overview at a Glance

5. Androgenetic Alopecia: Disease Background and Overview

6. Patient Journey

7. Androgenetic Alopecia Epidemiology and Patient Population

8. Treatment Algorithm, Current Treatment, and Medical Practices

9. Androgenetic Alopecia Unmet Needs

10. Key Endpoints of Androgenetic Alopecia Treatment

11. Androgenetic Alopecia Marketed Products

12. Androgenetic Alopecia Emerging Therapies

13. Androgenetic Alopecia: Seven Major Market Analysis

14. Attribute analysis

15. 7MM: Market Outlook

16. Access and Reimbursement Overview of Androgenetic Alopecia

17. KOL Views

18. Market Drivers

19. Market Barriers

20. Appendix

21. DelveInsight Capabilities

22. Disclaimer

23. About DelveInsight

 

Speak to expert @ https://www.delveinsight.com/sample-request/androgenetic-alopecia-market

 

About Us

DelveInsight is a Business Consulting and Market research company, providing expert business solutions for the life science vertical and offering quintessential advisory services in the areas of R&D, Strategy Formulation, Operations, Competitive Intelligence, Competitive Landscaping, and Mergers & Acquisitions.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Yash Bhardwaj
Email: Send Email
Phone: 9193216187
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/